Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaojing Xing, Xuguang Wang, Meichen Liu, Qianxue Guo & Hongyue Wang. (2023) Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells. Cancer Biology & Therapy 24:1.
Read now
Read now
Xiaokang Wang, Danwen Wang, Jinfeng Liu, Maohui Feng & Xiongzhi Wu. (2020) A novel CpG-methylation-based nomogram predicts survival in colorectal cancer. Epigenetics 15:11, pages 1213-1227.
Read now
Read now
Articles from other publishers (19)
Alex M. Woodworth, Kristine Hardy, Phillippa C. Taberlay, Joanne L. Dickinson & Adele F. Holloway. (2024) RUNX1 regulates promoter activity in the absence of cognate DNA binding motifs. Journal of Cellular Biochemistry.
Crossref
Crossref
Philip Chiu‐Tsun Tang, Max Kam‐Kwan Chan, Jeff Yat‐Fai Chung, Alex Siu‐Wing Chan, Dongmei Zhang, Chunjie Li, Kam‐Tong Leung, Calvin Sze‐Hang Ng, Yi Wu, Ka‐Fai To, Hui‐Yao Lan & Patrick Ming‐Kuen Tang. (2023) Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage–Myofibroblast Transition in Non‐Small‐Cell Lung Carcinoma. Advanced Science 11:1.
Crossref
Crossref
Isabella Wu & Xin Wang. (2023) A novel approach to topological network analysis for the identification of metrics and signatures in non-small cell lung cancer. Scientific Reports 13:1.
Crossref
Crossref
Xin Zou, Yue Zhang, Ning Wang, Jie Shi, Qinghai Li, Wanming Hao, Wenjing Zhu & Wei Han. (2022)
HEG1
as a novel potential biomarker for the prognosis of lung adenocarcinoma
. Cancer Medicine 12:3, pages 3288-3298.
Crossref
Crossref
Rodrigo da Silva Nunes Barreto, Gustavo de Sá Schiavo Matias, Milton Yutaka Nishiyama-Jr, Ana Claudia Oliveira Carreira & Maria Angelica Miglino. (2022) ECM proteins involved in cell migration and vessel formation compromise bovine cloned placentation. Theriogenology 188, pages 156-162.
Crossref
Crossref
Wensheng Zhang & Kun Zhang. (2022) A transcriptomic signature for prostate cancer relapse prediction identified from the differentially expressed genes between TP53 mutant and wild-type tumors. Scientific Reports 12:1.
Crossref
Crossref
Laia Bertran, Ailende Eigbefoh-Addeh, Marta Portillo-Carrasquer, Andrea Barrientos-Riosalido, Jessica Binetti, Carmen Aguilar, Javier Ugarte Chicote, Helena Bartra, Laura Artigas, Mireia Coma, Cristóbal Richart & Teresa Auguet. (2022) Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology. Biomedicines 10:6, pages 1315.
Crossref
Crossref
Miran Rada, Migmar Tsamchoe, Audrey Kapelanski-Lamoureux, Nour Hassan, Jessica Bloom, Stephanie Petrillo, Diane H. Kim, Anthoula Lazaris & Peter Metrakos. (2022) Cancer Cells Promote Phenotypic Alterations in Hepatocytes at the Edge of Cancer Cell Nests to Facilitate Vessel Co-Option Establishment in Colorectal Cancer Liver Metastases. Cancers 14:5, pages 1318.
Crossref
Crossref
Miran Rada, Audrey Kapelanski-Lamoureux, Stephanie Petrillo, Sébastien Tabariès, Peter Siegel, Andrew R. Reynolds, Anthoula Lazaris & Peter Metrakos. (2021) Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases. Communications Biology 4:1.
Crossref
Crossref
Tongqing Xue, Gang Yin, Weixuan Yang, Xiaoyu Chen, Cheng Liu, Weixi Yang & Jun Zhu. (2021) MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX1. Current Cancer Drug Targets 21:8, pages 702-712.
Crossref
Crossref
Francisco Alejandro Lagunas-Rangel. (2021) Deciphering the whale's secrets to have a long life. Experimental Gerontology 151, pages 111425.
Crossref
Crossref
Xiaodong Feng, Zhiwei Zheng, Yi Wang, Guanghui Song, Lu Wang, Zhijun Zhang, Jinxia Zhao, Qing Wang & Limin Lun. (2020) Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma. Experimental Biology and Medicine 246:5, pages 538-546.
Crossref
Crossref
Guangping Meng, Jinying Wei, Yanjun Wang, Danhua Qu & Jie Zhang. (2020) miR-21 regulates immunosuppression mediated by myeloid-derived suppressor cells by impairing RUNX1-YAP interaction in lung cancer. Cancer Cell International 20:1.
Crossref
Crossref
Songsong Liu, Fuming Xie, Lang Gan, Tao Peng, Xuejun Xu, Shixiang Guo, Wen Fu, Yunchao Wang, Yongsheng Ouyang, Jiali Yang, Xianxing Wang, Yao Zheng, Junfeng Zhang & Huaizhi Wang. (2020) Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation. Genomics 112:6, pages 5343-5355.
Crossref
Crossref
Basavaraj Vastrad & Chanabasayya Vastrad. (2020) Screening and identification of potential prognostic biomarkers in bladder urothelial carcinoma: Evidence from bioinformatics analysis. Gene Reports 20, pages 100658.
Crossref
Crossref
Dong Leng, Xiaoxi Huang, Jiawen Yi, Hongying Zhao & Yuhui Zhang. (2020) HYAL1 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits HFL-1 Fibroblast Proliferation When Upregulated. BioMed Research International 2020, pages 1-15.
Crossref
Crossref
Shuyan Liu, Yun Zhang, Chang Huang & Shengyun Lin. (2019) miR‐215‐5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway. Journal of Cellular Biochemistry 121:2, pages 1475-1490.
Crossref
Crossref
Yan-rong Zhao, Ji-long Wang, Cong Xu, Yi-ming Li, Bo Sun & Lian-yue Yang. (2019) HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Clinical Science 133:14, pages 1645-1662.
Crossref
Crossref
Shuo Zhao, Pengxiang Min, Lei Liu, Lin Zhang, Yujie Zhang, Yueyuan Wang, Xuyang Zhao, Yadong Ma, Hui Xie, Chenchen Zhu, Haonan Jiang, Jun Du & Luo Gu. (2019) NEDD9 Facilitates Hypoxia-Induced Gastric Cancer Cell Migration via MICAL1 Related Rac1 Activation. Frontiers in Pharmacology 10.
Crossref
Crossref